Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 17 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Pathobiology of cancer regimen-related toxicitiesDowney, G.; Sonis, S.; Keefe, D.
2008Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of lifeElting, L.; Keefe, D.; Sonis, S.; Garden, A.; Spijkervet, F.; Barasch, A.; Tishler, R.; Canty, T.; Kudrimoti, M.; Vera-Llonch, M.
2004Perspectives on cancer therapy-induced mucosal injury : Pathogenesis, measurement, epidemiology, and consequences for patientsSonis, S.; Elting, L.; Keefe, D.; Peterson, D.; Schubert, M.; Hauer-Jensen, M.; Bekele, B.; Raber-Durlacher, J.; Rubenstein, E.; Donelly, J.
2004Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositisRubenstein, E.; Peterson, D.; Schubert, M.; Keefe, D.; McGuire, D.; Epstein, J.; Elting, L.; Fox, P.; Cooksley, C.; Sonis, S.
2007Updated clinical practice guidelines for the prevention and treatment of mucositisKeefe, D.; Schubert, M.; Elting, L.; Sonis, S.; Epstein, J.; Raber-Durlacher, J.; Migliorati, C.; Hutchins, R.; Peterson, D.
2009Is the pathobiology of chemotherapy-induced alimentary tract mucositis inXuenced by the type of mucotoxic drug administered?Logan, R.; Stringer, A.; Bowen, J.; Gibson, R.; Sonis, S.; Keefe, D.
2008Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositisLogan, R.; Gibson, R.; Bowen, J.; Stringer, A.; Sonis, S.; Keefe, D.
2008Emerging drugs for chemotherapy-induced mucositisKeefe, D.; Sonis, S.; Bowen, J.
2014Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapyKeefe, D.; Elting, L.; Nguyen, H.; Grunberg, S.; Aprile, G.; Bonaventura, A.; Selva-Nayagam, S.; Barsevick, A.; Koczwara, B.; Sonis, S.
2016A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancerLacouture, M.; Keefe, D.; Sonis, S.; Jatoi, A.; Gernhardt, D.; Wang, T.; Doherty, J.; Giri, N.; Nadanaciva, S.; O'Connell, J.; Sbar, E.; Piperdi, B.; Garon, E.